Astek Diagnostics vs BillionToOne

<p>Astek Diagnostics offers the JIDDU platform, a clinical diagnostic software designed to confirm urinary tract infections (UTIs) and provide antibiotic sensitivity results in just one hour. This innovative tool drastically improves diagnostic speed and accuracy, helping you treat infections earlier and reduce patient complications and healthcare costs. The platform targets healthcare providers, enabling better clinical decision-making by eliminating guesswork in antibiotic prescriptions.</p> <p>With ongoing development to expand testing beyond urine to multiple sample types like CSF, effluent, and blood, Astek Diagnostics aims to create a universal diagnostic system. Partnering with reputable institutions, it focuses on reducing antibiotic resistance and improving patient outcomes by delivering rapid actionable results, making it a significant advancement in FemHealth and infection care.</p>

<p>BillionToOne offers cutting-edge healthcare software leveraging proprietary Quantitative Counting Templates (QCTs™) technology to enable highly precise DNA analysis. It provides non-invasive prenatal testing (NIPT) and liquid biopsy solutions that help you assess fetal risk for genetic conditions and monitor cancer treatment response using just one blood draw. This makes prenatal and oncology diagnostics more accessible and accurate for healthcare providers and patients.</p> <p>With BillionToOne, you gain powerful tools for prenatal risk assessment and real-time oncology therapy monitoring. Its UNITY Complete® product provides early fetal risk screening, while the Northstar platform supports pan-cancer testing for therapy selection and response tracking. The software caters to healthcare professionals aiming for improved patient outcomes through advanced molecular diagnostics.</p>